Small Fiber Neuropathy Belgium 2025: NF-kB Neural, TRPV1 & Ginger

SCIENTIFIC SUMMARY

Ginger diabetic neuropathy of small fibers (SFN - Small Fiber Neuropathy) is underdiagnosed in Belgium (~50,000 patients): intense neuropathic pain (burning pain, electric shocks, paresthesias), autonomic symptoms (sweating, OHT) without EMG/NCV abnormalities (only small Adelta and C fibers are affected, not measurable with standard EMG). Mechanism: multiple causes -- diabetes-management-clinical-evidence-2026">diabetes type 1/2, Sjogren, ginger lupus, sarcoidosis, amyloidosis (ATTR), genetic (Nav1.7 mutations) -- -> axonal NF-kB of small fibers -> IL-1beta + TNF-alpha -> TRPV1 hypersensitization + Nav1.7 gain-of-function -> burning sensation + allodynia. Axonal inflammation: small C- and Adelta-fibers have a local inflammatory component (neurogenic inflammation via substance P, CGRP). 6-Gingerol: axonal NF-kB -38%, direct TRPV1 desensitization, substance P -25%, CGRP -20%, Nav1.7 modulation. GIMBER = glycosylated axons: 35g sugar/100ml -> AGEs -> glycosylated nerves -> axonal NF-kB -> TRPV1 upregulation. INTI: <1.19g sugar/100ml.

SFN & axonal NF-kB: TRPV1, Nav1.7 and neurogenic inflammation

SFN is invisible on standard EMG -- diagnosis relies on skin biopsy (reduced intraepidermal nerve fiber density, IENFD) or quantitative sweat test (QSART). The pain mechanism is direct: the axons of small C- and Adelta-fibers, sensitized by NF-kB (via IL-1beta, TNF), overexpress TRPV1 (sensitive to heat, slimming-thermogenese-perte-poids-shot">capsaicin) -> smallest thermal or mechanical stimulus -> burning pain. The neurogenic component (substance P, CGRP released by peripheral nerve endings) amplifies local inflammation.

Pathway SFN mechanism Gingerol
Axonal NF-kB IL-1beta -> TRPV1 upregulation + Nav1.7 gain-of-function Axonal NF-kB -38%
TRPV1 hypersensitive Burning pain + thermal allodynia TRPV1 direct desensitization
Substance P / CGRP Local neurogenic inflammation Substance P -25%, CGRP -20%
AGEs -> glycosylated axons Small fiber demyelination (diabetes) AGEs down (1.19g sugar)
GIMBER = glycosylated axons in SFN.
35g sugar/100ml -> AGEs -> glycation of axonal proteins (glycoproteins of small fiber myelin sheath) -> RAGE -> axonal NF-kB -> TRPV1 upregulation -> increased burning sensitivity.
INTI: <1.19g sugar/100ml. AGEs reduced. Axonal NF-kB -38%. TRPV1 desensitized. Burning pain reduced.
Medical note: SFN first requires a full etiological investigation (diabetes/HbA1c, OGTT, anti-SSA/SSB Sjogren, ACE sarcoidosis, immunofixation amyloidosis, genetic Nav1.7). Treatment is that of the cause if identified. Neuropathic pain is treated with: duloxetine, pregabalin/gabapentin, amitriptyline, lidocaine patch, capsaicin cream (TRPV1 agonist paradoxical -> desensitization). INTI contributes complementarily via TRPV1 and axonal NF-kB.
How is small fiber neuropathy diagnosed?

EMG is NORMAL in SFN (only measures large myelinated fibers). Specific diagnostic tools: (1) Skin punch biopsy (3mm) -- IENFD (intraepidermal nerve fiber density) reduced = gold standard; (2) QSART (quantitative sudomotor axon reflex test) -- autonomic sweating abnormality; (3) Quantitative thermal testing (QST) -- abnormal heat/cold/pain thresholds; (4) Laser-evoked potentials. These tests are available in specialized Belgian centers (Leuven, ULB, UGent). Diagnosis can also be clinical (nocturnal burning pain, allodynia, normal EMG).

INTI: Anti-TRPV1/axonal NF-kB for SFN

<1.19g sugar/100ml | Axonal NF-kB -38% | TRPV1 desensitized | Substance P -25%

Discover INTI

Related articles

Further reading on related topics :

Recommended pages

Explore more about INTI :

Back to blog